DVADaVita

$180.08

The financials

DaVita by the numbers

DaVita (DVA) reported revenue of $3.55B in Q2 2026 (quarter ended June 30, 2026), up 5.2% from the same quarter a year earlier. That came with net income of $265M (7.5% of revenue). For the full year FY2025, revenue was $13.6B (+6.5% year on year) and net income $747M. Its largest segment in 2026-Q2 was U.S.Dialysis With Intersegment at $2.99B, 83% of the disclosed total, just ahead of Other Operating Segments With Intersegment at 10%.

DaVita income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$3.55B$3.38B+5.2%
Operating income$579M$538M+7.7%
Net income$265M$199M+33%
Diluted EPS$4.02$2.58+56%
Revenue by segment, 2026-Q2, as reported to the SEC
OperatingRevenueShare
U.S.Dialysis With Intersegment$2.99B83%
Other Operating Segments With Intersegment$372M10%
All Other$236M6.6%

Business Segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Q2 2026Total $3.60B (+2.3%)
Other Operating Segments With Intersegment grew +18% year on yearU.S.Dialysis With Intersegment +3.6% year on year
  • U.S.Dialysis With Intersegment$2.99BQoQ +2.7%year on year +3.6%
  • Other Operating Segments With Intersegment$372.4MQoQ +4.1%year on year +18%
  • All Other$236.4MQoQ -4.8%year on year +5.1%
Segment sum = 101% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-04, SEC EDGAR